• PIN29 Length of Stay and Cost Due to Recurrent Clostridium Difficile Infections (CDI) at a University Hospital in Finland

    Nov 1, 2012, 00:00

  • PMH15 An Economic Systematic Review on Bipolar Disorder in Children and Adolescents- Cost-Effectiveness of Treatments, Costs of Care and Quality of Life

    Nov 1, 2012, 00:00

  • PHP82 Health Care Utilization Research in Germany- Characterization of the Nordbaden Database

    Nov 1, 2012, 00:00

  • PHP26 Registries of Medical Devices in the European Union

    Nov 1, 2012, 00:00

  • PHP88 A Reimbursement Method for the Public Health Centers in Greece

    Nov 1, 2012, 00:00

  • PMH9 Cost Consequences of Non-Compliance in Schizophrenia Treatment – A Literature Review

    Nov 1, 2012, 00:00

  • PSU19 Does the Novel Renal Marker NGAL (Neutrophil Gelatinase-Associated Lipocalin) Result in Cost Savings in Patients With Renal Impairment Following Cardiac Surgery?

    Nov 1, 2012, 00:00

  • PRS5 Dual Bronchodilation With Indacaterol and Tiotropium in Combination Versus Triple Therapy, Fixed-Dose Combinations, and Monotherapy in COPD – a Network Meta-Analysis of FEV1

    Nov 1, 2012, 00:00

  • PIH44 Contraceptive Utilization in Women Who Had an Abortion- A Canadian Cohort-Study

    Nov 1, 2012, 00:00

  • PMS19 Indirect Costs Associated With Ankylosing Spondylitis in Turkey

    Nov 1, 2012, 00:00

  • PGI37 Finalisation and Psychometric Validation of a new Questionnaire Measuring Patient Satisfaction With Anti-TNF Treatments in Severe Crohn's Disease

    Nov 1, 2012, 00:00

  • PIH16 Epidemiology of Herpes Zoster and Its Related Resource Utilization- A Large Population-Based Study in Israel

    Nov 1, 2012, 00:00

  • PCV2 Comparative Efficacy and Safety Analysis of Atrial Fibrillaion Patients Treated with Dabigatran in RE-LY Study (CHADS 2 Score of 3 or Greater ) Versus Rivaroxaban in ROCKET-AF

    Nov 1, 2012, 00:00

  • PUK3 Evaluation on Health Expenditure Among Patients With Neurogenic Detrusor Overactivity After Spinal Cord Injury

    Nov 1, 2012, 00:00

  • PRM40 Efficacy of Liraglutide Compared to Exenatide and Insulin Glargine in Patients With Diabetes Type 2- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP152 The Early Benefit Assessment of Drugs That are Launched Before 2011

    Nov 1, 2012, 00:00

  • PDB34 Improvements in Quality of Life Associated With Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients in China- Results from the A1Chieve Observational Study

    Nov 1, 2012, 00:00

  • PIN13 The Clinical Burden of Hospitalized All-Cause Pneumonia in the Lombardia and Puglia Regions of Italy, 2007–2009

    Nov 1, 2012, 00:00

  • PDB49 Cost and Health Care Resources Utilization in the Management of Cushing'S Disease- An Analysis Based on the Ramq Database

    Nov 1, 2012, 00:00

  • PDB51 Resource Utilization in the Management of Acromegaly- An Analysis From Southwest Ontario

    Nov 1, 2012, 00:00

  • PHP91 Is There an Overuse of Computed Tomography (CT) Scanning of Patients in United States Hospitals? A Review of the Evidence

    Nov 1, 2012, 00:00

  • PRS23 Pharmacoeconomic Analysis of Roflumilast for Treatment of Adult Patients With Severe-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2012, 00:00

  • PMD81 Evaluation of Product Wastage From Modern Human Growth Hormone Administration Devices

    Nov 1, 2012, 00:00

  • Instructions for Authors

    Nov 1, 2012, 00:00

  • PCV51 Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Adult Patients With Non-Valvular Atrial Fibrillation with One or More Risk Factors – A UK Perspective

    Nov 1, 2012, 00:00

  • PGI22 Cost-Effectiveness Analysis of Dexlansoprazole for the Treatment of Erosive Esophagitis Compared to Conventional Proton Pump Inhibitors

    Nov 1, 2012, 00:00

  • PRM94 A New Step in the Use of Computer Adaptive Tests for Measuring Quality of Life. Cultural Adaptation and Calibration in Spain of Two Promis Item Banks- Pain-Behaviour and Pain-Interference

    Nov 1, 2012, 00:00

  • PSU3 Prolonged Effectiveness of Coronary Artery Bypass Surgery Versus Drug-Eluting Stents in Diabetics With Multi-Vessel Disease- An Updated Meta-Analysis

    Nov 1, 2012, 00:00

  • PHS95 The Suicidality in Thai Population- A National Survey

    Nov 1, 2012, 00:00

  • PDB9 Outcome of Fixed Dose Radioactive Iodine for the Treatment of Hyperthyroidism

    Nov 1, 2012, 00:00

  • PMD67 The Cost Effectiveness of Platelet Rich Plasma Versus Corticosteroids in the Treatment of Lateral Epicondylitis

    Nov 1, 2012, 00:00

  • PSS12 Nepafenac for the Reduction in Risk of Post-Operative Macular Oedema Associated With Cataract Surgery in Diabetic Patients- A Cost-Effectiveness Estimation for Scotland

    Nov 1, 2012, 00:00

  • PHP70 A Systematic Review of Hospital-at-Home Care- Cost Savings are Overestimated

    Nov 1, 2012, 00:00

  • PR4 Trends in Pricing and Reimbursement Schemes From 1994-2011

    Nov 1, 2012, 00:00

  • PHP64 Analyzing the Annual Adverse Drug Reactions at a Regional Teaching Hospital of Southern Taiwan

    Nov 1, 2012, 00:00

  • PHP85 The Benefits of Using OTC- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PMH44 Validity and Responsiveness of the EQ-5D and the Kidscreen-10 in Children With ADHD

    Nov 1, 2012, 00:00

  • PMH49 Horizon Scanning of Molecular Imaging Methods in Psychiatric Disorders

    Nov 1, 2012, 00:00

  • PHP4 Financial Penalties for Improving Drug Adherence

    Nov 1, 2012, 00:00

  • PHP184 Changing Margins in Pharmaceutical Distribution- Who Benefits from the New Slicing of the Pie?

    Nov 1, 2012, 00:00

  • PIN15 Economic Evaluation of Vaccination in Southeast Asian Countries- A Systematic Review

    Nov 1, 2012, 00:00

  • PHP19 Consumption of Drugs for Peptic Ulcer and Gastroesophageal Reflux Disease- Striking Differences Between Serbia and Norway

    Nov 1, 2012, 00:00

  • PDB3 Epidemiology, Patient Burden and Related Costs of Obesity in China

    Nov 1, 2012, 00:00

  • PHP126 From Innovation to Market Access- Reimbursement Strategies of Medical Industry in Dutch Health Care

    Nov 1, 2012, 00:00

  • PHS83 Potential Time Savings With Rituximab Subcutaneous (SC) Injection Versus Rituximab Intravenous (IV) Infusion- Results from Interviews at 13 European Sites As Part of a Time and Motion Study (TM)

    Nov 1, 2012, 00:00

  • PDB30 The Pattern and Prescription Cost Among Diabetic Patients in the HO Municipal Hospital, Volta Region, Ghana

    Nov 1, 2012, 00:00

  • PHP180 Multiple Correspondence Analysis to Understand the Role of Multiprofessional Team for Shared Decision Making to Implementation in Clinical Practice

    Nov 1, 2012, 00:00

  • PHP107 Experts' Views on the Introduction of a Monopsony in Health Care Services in Greece

    Nov 1, 2012, 00:00

  • PHP42 Health Economics in the Czech Republic and Insurance Coverage Decision Making in 2008-2009- A Retrospective Analysis

    Nov 1, 2012, 00:00

  • PHP178 Validity of Self-Reported Health Care Utilization- Towards a Research Consensus

    Nov 1, 2012, 00:00

  • PRM173 On the Probability of Intertemporal Indifference

    Nov 1, 2012, 00:00

  • PMS46 Economic Evaluation of Adalimumab for the Treatment of Early-and Late-Stage Rheumatoid Arthritis in Italy

    Nov 1, 2012, 00:00

  • PMS11 Budget Impact Analysis in Spanish Patients With Dupuytren's Contracture- Fasciectomy Versus Collagenase Clostridium Histolyticum

    Nov 1, 2012, 00:00

  • PDB4 HbA1C Reduction Associated With Initial Versus Sequential Combination Therapy With Pioglitazone (PIO) and Dipeptidyl Peptidase-4 Inhibitors (DPP4i) in Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PMH37 Systematic Review of Health State Utilities in Attention Deficit Hyperactivity Disorder (ADHD)

    Nov 1, 2012, 00:00

  • PHP139 Which Criteria are Considered in Health Care Decisions? Insights from an International Survey of Policy and Clinical Decision Makers

    Nov 1, 2012, 00:00

  • PHP29 Innovative Technologies - Factors Influencing Financing Decisions in Italian Hospitals

    Nov 1, 2012, 00:00

  • PCV66 Pharmacoeconomic Analysis of Azilsartan Medoxomil in Patients With Arterial Hypertension- Comparison With Valsartan, Telmisartan, Losartan and Irbesartan in the Mexican Context

    Nov 1, 2012, 00:00

  • PIN27 Cost Analysis of Voriconazole Versus Liposomal Amphotericin B for Primary Therapy of Invasive Aspergillosis Among Hematologic Patients in Germany

    Nov 1, 2012, 00:00

  • PDB2 Systematic Literature Review of the Efficacy and Safety of Metformin Extended Release Relative to Metformin Immediate Release in the Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PUK1 A Swedish Prospective Observational Study to Evaluate the Impact in Quality of Life Among Previously Untreated Patients Receiving Their First Prescription of Solifenacin. (SPOQ-Study)

    Nov 1, 2012, 00:00

  • PMD46 Economic Analysis of a Predictive Test for Taxane Response in Early Breast Cancer Patients in the UK

    Nov 1, 2012, 00:00

  • PR1 Does Medication Adherence Correlate With Health-Related Quality of Life? Findings From a Descriptive Analysis

    Nov 1, 2012, 00:00

  • PIH36 Quality of Life of Medical University of Warsaw Faculty of Pharmacy Students in 2010-2012

    Nov 1, 2012, 00:00

  • PMD89 Diagnostic Accuracy of Early Biomarkers for Acute Coronary Syndrome (ACS)

    Nov 1, 2012, 00:00

  • PIN28 Cost-of-Illness Analysis of Candidemia in Patients on the Intensive Care Unit

    Nov 1, 2012, 00:00

  • PSU5 Bariatric Surgery From the Perspective of Brazilian National Health System (SUS)

    Nov 1, 2012, 00:00

  • PSY29 Title- The Challenge of Conducting a Prospective Economic Evaluation of a Pharmacogenetic Test

    Nov 1, 2012, 00:00

  • PGI34 A Patient-Reported Outcome Model for Crohn's Disease

    Nov 1, 2012, 00:00

  • PDB40 The Importance of HbA1C Evolution in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • ME1 Comparison of the Measurement Properties Between the 5-Level EuroQoL Group's 5-Dimension (EQ-5D-5L) Questionnaire and the Functional Assessment of Cancer Therapy – Breast (FACT-B) in Asian Breast Cancer Patients

    Nov 1, 2012, 00:00

  • PDB29 Cost-Effectiveness Modelling of Type-1 Diabetes

    Nov 1, 2012, 00:00

  • PRS13 Discriminating the Price of a Product Based on the Target Patient Segment by Launching Different Delivery Mechanisms- A Comparison of China, India and Korea

    Nov 1, 2012, 00:00

  • PRM34 Routine Data in HTA- Record Linkage in Austrias GAP-DRG Database

    Nov 1, 2012, 00:00

  • PMD29 Comparing the Economic Impact of Prosthesis Choice in Unicompartmental Knee Arthroplasty Procedures- Development of an Economic Model

    Nov 1, 2012, 00:00

  • PR4 The Effect of Neuropathic Pain on Health Status, Work Productivity Loss, and Health Care Resource Use in Japan

    Nov 1, 2012, 00:00

  • PHP187 Pharmacovigilance and the Case Study of VIOXX

    Nov 1, 2012, 00:00

  • PCN158 Adherence to Human Epidermal Growth Factor Receptor-2 (HER2) Testing Adjuvant Trastuzumab Treatment Guidelines in a Canadian Province

    Nov 1, 2012, 00:00

  • PSS8 Health Burden of Vision Problems in Asia- A Study of Malays and Indians in Singapore

    Nov 1, 2012, 00:00

  • PND63 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis- Findings From the Phase 3 Define Study

    Nov 1, 2012, 00:00

  • PRM91 How Do Patients With Different Conditions Describe Their Pain?

    Nov 1, 2012, 00:00

  • PGI7 the Cost-Effectiveness of Rotavirus Vaccination in Guangzhou, China

    Nov 1, 2012, 00:00

  • PMH25 An Assessement of the Cost-Effectiveness of Escitalopram Versus Multiple Comparators as First Line Antidepressant in Patients With Major Depressive Disorder (MDD) in Belgium

    Nov 1, 2012, 00:00

  • PDB5 Real-World Treatment Patterns and Outcomes When Initiating Once-Daily Injectable Pen Therapy with Insulin Glargine or Liraglutide – an Electronic Medical Records Study

    Nov 1, 2012, 00:00

  • MO2 Impact of Structural Assumptions on Cost-Effectiveness Outcomes- Towards a Standardized Cost-Effectiveness Model for Adjuvant Breast Cancer Therapies

    Nov 1, 2012, 00:00

  • PMS10 Hospitalization Costs and Their Predictors in Patients with Rheumatoid Arthritis in Urban China

    Nov 1, 2012, 00:00

  • PMS63 Assessment of the Osteoporosis Self-Efficacy Scale in Relation to Osteoprotective Behaviors among Type 2 Diabetics Patients in North Malaysia

    Nov 1, 2012, 00:00

  • PHS34 The Cost of Management of Common Cardiovascular Diseases is Higher on Weekends As Compared to Weekdays

    Nov 1, 2012, 00:00

  • PUK15 Sevelamer in Early Stages Nondialysis-Dependent Chronic Kidney Disease (NDD-CKD) Dominates Calcium Carbonate Through Reduction of Deaths and Hospitalizations

    Nov 1, 2012, 00:00

  • PMH50 Differences in Treatment Patterns and Characteristics in Patients With Bipolar Disorder - A Retrospective Real Life Study in Sweden

    Nov 1, 2012, 00:00

  • PHP103 Challenges and Future Prospects of Nursing Workforce in Greece

    Nov 1, 2012, 00:00

  • PMS65 Detecting Potential Fibromyalgia Patients in Primary Care Settings- Validation of the Fibrodetect Screening Tool

    Nov 1, 2012, 00:00

  • PHP110 Real-World Diagnosis and Treatment Patterns of Iron Deficiency Anemia in China

    Nov 1, 2012, 00:00

  • PIH10 Utility Values for Use in Health Care Decision Making for Older Frail Adults

    Nov 1, 2012, 00:00

  • PCN159 Melody Brazil - Treatment Patterns in Brazilian Health Care System

    Nov 1, 2012, 00:00

  • PIH45 Comparison of Unintended Pregnancy Rates in Users of 84/7, 21/7, and 24/4 Oral Contraceptive Regimens

    Nov 1, 2012, 00:00

  • PMD66 Health-Economic Analysis of the Systematic Use of Single-Hand Secured Huber Needles (Positive-Pressure) in French Hospitals

    Nov 1, 2012, 00:00

  • PHP60 Assessment of Geographic Pharmacy Accessibility in Qom (Iran)- a Geographic Information System Analysis

    Nov 1, 2012, 00:00

  • PMH48 Public Beliefs and Attitudes About Schizophrenia, Major Depression and Psychotropic Medication

    Nov 1, 2012, 00:00

  • PRM86 Utilizing Indirect Treatment Comparisons in Metastatic Castration Resistant Prostate Cancer (mCRPC)

    Nov 1, 2012, 00:00

  • PHP54 Chemical Drug Price Index Study

    Nov 1, 2012, 00:00

  • PCN16 Comparison of the Efficacy and Cost of Novel Targeted Cancer Therapies

    Nov 1, 2012, 00:00

  • PCV24 Economic Analysis of Bemiparin and Enoxaparin Used for Thrombosis and Embolism Prevention in Orthopedic Patients in Russia

    Nov 1, 2012, 00:00

  • PCN18 Economic Evaluation of CT Colonography (CTC) Introduction Into the Colorectal Cancer Screening Program in Japan

    Nov 1, 2012, 00:00

  • PND34 Long-Term Effects on Costs and Quality Adjusted Life Years of Patients With Relapsing-Remitting Multiple Sclerosis Treated With Laquinimod- Results Based on the Allegro and Bravo Trials

    Nov 1, 2012, 00:00

  • PRS1 The Use of Montelukast and Neuropsychiatric Disturbances Among Pediatric Asthmatics- A Nested Case-Control Study

    Nov 1, 2012, 00:00

  • PHP15 Comparison of Health Expenditures and Drug Expenditures in Two Western Balkan Countries

    Nov 1, 2012, 00:00

  • PDB19 Estimating the Costs of Diabetes Mellitus- An Analysis in Malaysia

    Nov 1, 2012, 00:00

  • PMS1 Irrational Use of Steroids- A Warning for the Health Care System

    Nov 1, 2012, 00:00

  • PHP101 The Implementation of Diagnostic Related Groups (DRGs) in Gree One Move Forward to Efficiency

    Nov 1, 2012, 00:00

  • PCN43 Cost Assessment of Companion Diagnostics in Breast Cancer

    Nov 1, 2012, 00:00

  • PCN45 Economic Evaluation of Using Branded Taxotere® Versus Generic Docetaxel- Based on Decision Tree Model

    Nov 1, 2012, 00:00

  • PMS69 Key Drivers for Pricing and Reimbursement for Biologic Drugs in France

    Nov 1, 2012, 00:00

  • PCV55 A Cost-Effectiveness Analysis of Coralan® (Ivabradine) Plus Standard Care Versus Standard Care Alone in Chronic Heart Failure

    Nov 1, 2012, 00:00

  • PCV65 A Health Economic Evaluation of Omega-3 Acid Ethyl Esters 90 in the Secondary Prevention Post-MI

    Nov 1, 2012, 00:00

  • PSU15 Clinical and Economic Burden of Anastomotic Leaks After Colorectal Surgeries

    Nov 1, 2012, 00:00

  • PIN4 The Impact of Pharmacist-Led Antimicrobial Stewardship in Intensive Care Units in a Regional Hospital in Taiwan

    Nov 1, 2012, 00:00

  • PHP65 Quality of Care- Reference and Counter Reference from Family Physicians and Rheumatologists' Perspectives– A Pilot Study

    Nov 1, 2012, 00:00

  • PHP98 Patients Preferences Versus Physicians Judgment- Is There a Difference in Health Care Decision Making?

    Nov 1, 2012, 00:00

  • PHP43 How Will Health Care Reform in Russia Affect Drug Pricing and Reimbursement?

    Nov 1, 2012, 00:00

  • PIN16 Cost-Effectiveness of Rotavirus Immunization in Indonesia Taking Breastfeeding Patterns Into Account

    Nov 1, 2012, 00:00

  • PRM21 Communicating to Decision Makers the Parameter Uncertainty in the IQWiG Efficiency Frontier Approach

    Nov 1, 2012, 00:00

  • PMS16 Economic Burden of Juvenile Idiopathic Arthritis in Russia

    Nov 1, 2012, 00:00

  • PMD74 The Relationship Between Treatment Satisfaction and Health Status among Those With Type 1 Diabetes

    Nov 1, 2012, 00:00

  • PHS58 Change in Health-Related Quality of Life After Occpational Therapy in Community-Dwelling Dependent Elderly- A Randomised Controled Trial

    Nov 1, 2012, 00:00

  • PCN127 Policy Maker, Please Carefully Consider Your Needs- Does Outcomes Research of Bortezomib for Advanced Multiple Myeloma Reduce Uncertainty?

    Nov 1, 2012, 00:00

  • PCN25 A Population-Based Prediction of Breast Cancer in Russian Federation- Analysis HER2-Status Groups for Target Treatment

    Nov 1, 2012, 00:00

  • PHS44 Economic Evaluation of Universal Hepatitis B Vaccination Strategy in Japan

    Nov 1, 2012, 00:00

  • PSY37 Patient-Reported Outcome (PRO) Assessments in Systemic Lupus Erythematosus (SLE)

    Nov 1, 2012, 00:00

  • PCN9 Modeling Lifetime Effectiveness of Denosumab Versus Placebo in Men With Castration Resistant Prostate Cancer (CRPC) at High Risk of Developing Bone Metastasis (BM)

    Nov 1, 2012, 00:00

  • PIN36 Six Years Observational Study of the Cost of Highly Active Antiretroviral Therapy and HIV/AIDS Control

    Nov 1, 2012, 00:00

  • PSS10 Economical Burden of Severe Visual Impairment and Blindness – a Systematic Review

    Nov 1, 2012, 00:00

  • DB4 Patient-Reported Hypoglycaemia in Real-World Settings in Seven European Countries

    Nov 1, 2012, 00:00

  • PMH45 Health-Related Quality of Life Patient-Reported Outcomes in Schizophrenia

    Nov 1, 2012, 00:00

  • PHP51 Perception of Parallel Trade of Pharmaceuticals in Poland – Results of National Market Research

    Nov 1, 2012, 00:00

  • PMH43 Modelling the Longitudinal Latent Effect of Pregabalin on Self-Reported Changes in Sleep Disturbances and Disability in Outpatients With Generalized Anxiety Disorder (GAD) Treated in Routine Clinical Practice in Spain

    Nov 1, 2012, 00:00

  • PMD37 Forecasting the Prevalence and Economic Burden of Atrial Fibrillation in Selected Countries, 2010-2025

    Nov 1, 2012, 00:00

  • PCN19 Cost-Effectiveness Analysis of Temsirolimus in Patients With Poor Risk Renal-Cell Carcinoma

    Nov 1, 2012, 00:00

  • PIH17 Cost Benefit Analysis on the Long Term Effects of in Vitro Fertilization (IVF) in Gree An Analysis Based on a Lifetime Model

    Nov 1, 2012, 00:00

  • PUK5 Clinical and Economic Impacts of Clinical Pharmacy Education on Infection Management Among Patents With Chronic Kidney Disease in a Hospital (Indonesia)

    Nov 1, 2012, 00:00

  • PIN2 Estimating the Additive Effects of Length of Stay on Contracting Clostridium Difficile Infection

    Nov 1, 2012, 00:00

  • PHS12 Meta-Analysis of Parkinson's Disease Risk With Hypertension, Serum Total Cholesterol, and Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PIH19 Cost Effectiveness of Premalex (Escitalopram) Compared to Sertraline for Treatment of PMDD (Premenstrual Dysphoric Disorder), Based Upon the CGI-S

    Nov 1, 2012, 00:00

  • PDB5 Statin is a Reasonable Treatment Option for Patients With Polysystic Ovary Syndrome- A Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2012, 00:00

  • PND56 Assessing the Quality of Life in a Spanish Population With Multiple Sclerosis- The Slims Study

    Nov 1, 2012, 00:00

  • PDB11 Efficacy of Exentaide in Type 2 Diabetes Mellitus in a Local Hospital in Taiwan- a Pilot Study

    Nov 1, 2012, 00:00

  • PND44 Cost-Utility Analysis and Cost-Minimisation Analysis of Sabril® (Vigabatrin) in Drug-Resistant Epilepsy From Payer's Perspective in Poland

    Nov 1, 2012, 00:00

  • PRS21 Cost-Effectiveness of Budesonide/Formoterol Versus Fluticasone/Salmeterol Based on Real-World Effectiveness in Patients With COPD

    Nov 1, 2012, 00:00

  • MA1 Utilization of Disease Modifying Agents in Multiple Sclerosis- Analysis From an Italian Administrative Database

    Nov 1, 2012, 00:00

  • PRS46 Health Care Resource Use of Patients With Cystic Fibrosis (CF) in the UK

    Nov 1, 2012, 00:00

  • PSU10 Costs of Cardiovascular Readmissions Following Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease- Data From a Large Multi-Centre Australian Registry

    Nov 1, 2012, 00:00

  • PSS19 Economic Evaluation of Ranibizumab for the Treatment of Macular Edema Secondary to Branch and Central Retinal Vein Occlusion in Canada

    Nov 1, 2012, 00:00

  • PMS59 Impact of Comorbidities on Measuring Indirect Utility by the Medical Outcomes Study Short Form 6D in Lower-Limb Osteoarthritis

    Nov 1, 2012, 00:00

  • PRM23 Cost-Effectiveness Versus Patient Acceptability- The Exemplar of CFS/ME

    Nov 1, 2012, 00:00

  • PSY26 Cost-Effectiveness of Hematopoietic Stem Cell Mobilization Strategies in Multiple Myeloma and Lymphoma Patients in Czech Republic

    Nov 1, 2012, 00:00

  • PIN13 Cost of Antibiotics Used for Nosocromaial Infection Treatment in Inpatient Department at Nakhon Pathom Hospital

    Nov 1, 2012, 00:00

  • PMD61 Cost-Effectiveness of Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma- A Systematic Review

    Nov 1, 2012, 00:00

  • DU4 Inappropriate Use of Drugs Influences Health Budget of Population

    Nov 1, 2012, 00:00

  • PCV17 A Cross-Sectional Assessment of Atrial Fibrillation Management Among French Patients in Primary Care

    Nov 1, 2012, 00:00

  • PIN86 Clinical and Economic Burden of Community Acquired Pneumonia in 7 Countries. A Comparison With Invasive Pneumococcal Disease

    Nov 1, 2012, 00:00

  • PSY38 Spontaneous and Probed Disease-Defining Concepts Identified Through Concept Elicitation Interviews in Chronic Low Back Pain

    Nov 1, 2012, 00:00

  • PRS39 Preference and Willingness to Pay for a Treatment of Pulmonary Arterial Hypertension

    Nov 1, 2012, 00:00

  • PHS3 Assessing the Survival Rates and Economic Burden of Prostate Cancer in the United States Veteran Population

    Nov 1, 2012, 00:00

  • PDB26 Effect of Diabetes Disease Management Programs Based on Bundled Payment on Curative Health Care Costs in the Netherlands

    Nov 1, 2012, 00:00

  • PCV30 Cost-Effectiveness of Cilostazol, Naftidrofuryl Oxalate, Pentoxifylline and Inositol Nicotinate for the Treatment of Intermittent Claudication in People with Peripheral Arterial Disease in the Uk

    Nov 1, 2012, 00:00

  • PHS5 Assessing the Clinical and Economic Burden of United States Veteran Ankylosing Spondylitis Patients

    Nov 1, 2012, 00:00

  • PCV13 Are Statins Effective to Prevent First Non-Fatal Myocardial Infarction in Real Life in a Low-Risk Country? A Population-Based Case-Referent Study Using the PGRx Information System

    Nov 1, 2012, 00:00

  • PRS44 The Impact Made by the Continuity of Care for COPD Patients on Health Outcomes and Medical Cost in Korea, According to the National Health Insurance Database

    Nov 1, 2012, 00:00

  • PDB60 Preliminary Results on the Reliability and Validity of the Worry Subscale of the Hypoglycaemic Fear Survey-II for Assessing the Impact of Fear for Hypoglycemia on the Health-Related Quality of Life of Type 2 Diabetes Mellitus Patients ...

    Nov 1, 2012, 00:00

  • PMD65 The Cost Effectiveness of Hand Held Ultrasound Scanning for AAA in Elderly Subjects With a History of Smoking

    Nov 1, 2012, 00:00

  • PRS42 Current Position of ICS/LABA Combination Therapy in Asthma and COPD in Primary and Secondary Care in Germany – Delphi Consensus Research

    Nov 1, 2012, 00:00

  • PMS11 The Inpatient Costs and Their Predictors in Patients with Ankylosing Spondylitis in China

    Nov 1, 2012, 00:00

  • PCN138 Patterns of Anticoagulant Use in Cancer Patients Receiving Chemotherapy

    Nov 1, 2012, 00:00

  • PCV93 Study of the Use of Quality of Life Questionnaires in Cardiac Diseases in Poland

    Nov 1, 2012, 00:00

  • PHP45 Relapse Prevention After Switching to Risperidone Long-Acting Ingection- 6 Months Mirror Image Study in Japan

    Nov 1, 2012, 00:00

  • PRM53 Can the Disutility of Allergic Rhinitis and Conjunctivitis Be Calculated From the Aggregated Total Symptoms Score?

    Nov 1, 2012, 00:00

  • PND3 Relapses Requiring Intravenous Steroids and Multiple Sclerosis-Related Hospitalizations- Findings From the Phase 3 Define and Confirm Studies

    Nov 1, 2012, 00:00

  • PRS7 The Effect of Chronic Obstructive Pulmonary Disease (COPD) on Health Status in Urban China

    Nov 1, 2012, 00:00

  • PCV1 Angiotensin Receptor Blockers and the Risk of Myocardial Infarction- Network Meta-Analysis and Probability Ranking

    Nov 1, 2012, 00:00

  • PHP198 From Science to Servi The Ontario Patient Reported Outcomes of Symptoms and Toxicity (On-PROST) Research Unit

    Nov 1, 2012, 00:00

  • PMS4 Comparing the Efficacy and Safety of Biologics for the Treatment of Rheumatoid Arthritis Patients- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PCV23 Beta Blockers for Treatment of Chronic Heart Failure in Spain- Review of the Economic Evidence and Efficiency Analysis

    Nov 1, 2012, 00:00

  • PGI3 Determination of Efficacy, Adverse Drug Reactions and Cost Effectiveness of Three Triple Drug Regimens for the Treatment of H. Pylori Infected Acid Peptic Disease Patients

    Nov 1, 2012, 00:00

  • PSY21 Cost-Effectiveness of Posaconazole Versus Fluconazole in the Prophylaxis of Invasive Fungal Infections in Patients With Graft-Versus-Host Disease (GVHD) in Turkey

    Nov 1, 2012, 00:00

  • PRM140 An Applied Comparison of Meta-Analysis Techniques Using Bacille Calmette Guerin Vaccine Studies

    Nov 1, 2012, 00:00

  • PCV94 The Influence of Disease-Specific Symptoms on the Health-Related Quality of Life in Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PDB6 Predictors of Reaching HbA1C Goal in T2Dm Patients Using Dipeptidyl Peptidase-4 Inhibitors (DPP4Is) Combination Therapy- A Subgroup Analysis

    Nov 1, 2012, 00:00

  • PSY33 Item Reduction and Assessment of Measurement Properties of the Hunter Syndrome – Functional Outcomes for Clinical Understanding Scale (HS-FOCUS)

    Nov 1, 2012, 00:00

  • PCN88 Cost-Effectiveness Analysis Per Life-Year Gained Based on Predictors of Response for First Line Metastasic Colorectal Cancer Therapy in Spain

    Nov 1, 2012, 00:00

  • PMS19 Investigation of Comparative Clinical Outcomes Profiles and Cost Effectiveness of Four Classes of Anti Arthritic Drugs Using HAQ DI, DAS -28 and EQ5D3L in a Tertiary Care Hospital in Western India

    Nov 1, 2012, 00:00

  • PCN97 Pharmacoeconomic Analysis of the Prostate Cancer Therapy with Gonadotropin-Releasing Hormone Analogues- Leuprorelin, Goserelin, Triptorelin

    Nov 1, 2012, 00:00

  • PHS70 Health Related Quality of Life As Predictor of Death Among Patients With Heart Failure

    Nov 1, 2012, 00:00

  • PMH40 How do Patients Describe Their Depression? - Incorporating the Patient's Voice Into Instrument Development

    Nov 1, 2012, 00:00

  • PCV30 Assessment of the Hospital Costs of Mitral Regurgitation (MR) Patients, a French National Hospital Database Analysis

    Nov 1, 2012, 00:00

  • PHP21 Does National Essential Medicine System Improve Rational Drug Use in Primary Health Care Facilities? An Empirical Study in Rural China

    Nov 1, 2012, 00:00

  • PIN4 Mixed-Treatment Comparison of the Efficacy and Safety of Antiretroviral Drugs Indicated for Treatment-Experienced HIV Patients

    Nov 1, 2012, 00:00

  • PDB10 Effectiveness of Vildagliptin Compared to Sulfonylureas in Type 2 Diabetes Patients in Germany- Results From a Large Real-Life Cohort Study

    Nov 1, 2012, 00:00

  • PHP162 Review of NICE's Technology Appraisal Recommendations

    Nov 1, 2012, 00:00

  • PHP108 Pattern of Antibiotics Usage in Malaysian Hajj Pilgrim

    Nov 1, 2012, 00:00

  • PMD68 Cost-Effectiveness of Sacral Neuromodulation in the Treatment of Idiopathic Wet Refractory Overactive Bladder in Italy

    Nov 1, 2012, 00:00

  • PHS62 Assessment of Patient Satisfaction With Chronic Treatment Using the European Patient Survey in Atrial Fibrillation (EUPS-AF)

    Nov 1, 2012, 00:00

  • PCN3 Quality-Adjusted Survival in Patients With Wild-Type (WT) KRASs Metastatic Colorectal Cancer (mCRC) Receiving First-Line Therapy With Panitumumab Plus FOLFOX Versus FOLFOX Alone

    Nov 1, 2012, 00:00

  • PCN7 A Systematic Review of the Heterogeneity of Treatment Effect in Ovarian Cancer (OC)—Are There Implications for Outcomes Research?

    Nov 1, 2012, 00:00

  • PND23 Economic Burden of Illness for Persons With Spina Bifida (SB) in Germany

    Nov 1, 2012, 00:00

  • PND27 Assessment of Informal Care Provided to Patients With Multiple Sclerosis and Limitation of Personal Autonomy

    Nov 1, 2012, 00:00

  • PDB32 Diabetic Foot Syndrome Hospitalization Costs in Poland

    Nov 1, 2012, 00:00

  • PCN79 Pharmacoeconomic Evaluation of Acute Myeloid Leukemia and MDS Syndromes (Intermediate and High Risk) Treatment With Azacitidine in the Russian Federation

    Nov 1, 2012, 00:00

  • PRM76 A Treatment Sequence Approach for Modelling Crohn's Disease

    Nov 1, 2012, 00:00

  • PIN62 Cost-Effectiveness of Triple Therapy With Telaprevir for the Treatment of Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients in Germany

    Nov 1, 2012, 00:00

  • PGI2 Infliximab Reduces the Risk of Surgical Interventions and Hospitalization in Patients With Inflammatory Bowel Disease

    Nov 1, 2012, 00:00

  • PHP7 How Do Reimbursement Systems Encourage or Inhibit Adoption of Innovative Medical Devices in an Ambulatory Setting?

    Nov 1, 2012, 00:00

  • PHP6 Comparing the Effectivness of Different Educational Programs for Children on Appropriate Antibiotic Use

    Nov 1, 2012, 00:00

  • PDB23 Cost Effectiveness of Angipars™ in the Treatment of Diabetic Foot Ulcers in Iran

    Nov 1, 2012, 00:00

  • PGI35 Health-Related Quality of Life in Patients With Haemophilia and Inhibitors on Prophylaxis With Anti-Inhibitor Complex Concentrate- Results From the Pro-Feiba Study

    Nov 1, 2012, 00:00

  • PMD73 Quality of Life and Resource Use After Transcatheter Aortic Valve Implantation. Preliminary Results of an Observational Multicentre Study

    Nov 1, 2012, 00:00

  • PCV38 Economic Evaluation of Anticoagulant Strategies in Interventional Treatment of Acute Myocardial Infarction

    Nov 1, 2012, 00:00

  • PIH34 Identifying Individuals with Different Time Preferences in Time Trade-Off Valuations of Hypothetical Health States- A Latent Class Analysis of the US EQ-5D-3L Valuation Data

    Nov 1, 2012, 00:00

  • PND22 Descriptive Analysis of the Direct Costs of Relapsing-Remitting Multiple Sclerosis in the Mexican Setting

    Nov 1, 2012, 00:00

  • PIH26 Social Impact of Adalimumab in the Italian Perspective

    Nov 1, 2012, 00:00

  • PHP117 Study on the Health Insurance Coverage Among Poor and Disadvantaged Citizens

    Nov 1, 2012, 00:00

  • PDB1 Risk Factors for Hypoglycemia Among Veterans With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PHS14 Clinical and Economic Analysis of “MoliCare® Premium Extra Soft” Diapers Efficient Application for Dermatitis and Pressure Ulcers' Prophylaxis for Immobile Urinary-Incontinent Patients

    Nov 1, 2012, 00:00

  • PDB70 Characteristics of Long-Acting Somatostatin (SSA) Use in Acromegaly in the Netherlands

    Nov 1, 2012, 00:00

  • CE3 Hyperbaric Oxygen Therapy for the Treatment Non-Neurological Soft Tissue Radiation Injuries- a Cost Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PHS86 A Population-Based Study of the Resource Utilization and Costs of Treating Resectable Non-Small Cell Lung Cancer

    Nov 1, 2012, 00:00

  • PIN37 The Economic Burden of Initial Empiric Antibiotic Failure on Health Care Resource Utilization for Hospitalized Patients With Complicated Intra-Abdominal Infections (cIAIs) in Greece

    Nov 1, 2012, 00:00

  • PCV42 Model Sensitivity Analysis of Venous Thromboembolism Prevention After Total Hip Replacement

    Nov 1, 2012, 00:00

  • PCN26 Health State Utilities for Relapsed/Refractory (Rel/Ref) Hodgkin'S Lymphoma (HL) and Systemic Anaplastic Large-Cell Lymphoma (sALCL)- Asian Pacific Country Data

    Nov 1, 2012, 00:00

  • PCN86 Cost-Effectiveness Analysis of Abiraterone for the Treatment of Advanced Prostate Cancer Under the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PHP75 Is Orphan Designation a Driver of Orphan Drug Pricing?

    Nov 1, 2012, 00:00

  • PMS54 A Retrospective Cohort Study of Persistence Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary

    Nov 1, 2012, 00:00

  • PMS74 Application of Data Visualization Tool- Treatment Patterns of Veteran Patients With Ankylosing Spondylitis Who Initiated Tumor Necrosis Factor Therapy

    Nov 1, 2012, 00:00

  • PND66 Therapeutic Equivalence as a Means of Improving the Efficiency in the Treatment of Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PRS47 Analysis of New Prescriptions for Long-Acting β2-Agonists in Five European Countries in 2011

    Nov 1, 2012, 00:00

  • PMD3 Pre-Screening Tools- A Neglected Approach to Diagnose and Cut Cost Associated With Osteoporosis

    Nov 1, 2012, 00:00

  • PCN10 Examining the Use of Rescue Antiemetic Medication for Chemotherapy Induced Nausea and Vomiting in a Commercial Population

    Nov 1, 2012, 00:00

  • PCN3 Improvement of the 3rd Generation Colorectal Cancer Gene Chip

    Nov 1, 2012, 00:00

  • PHP161 Integration of Value of Information Into the Decision Making Process in Ireland

    Nov 1, 2012, 00:00

  • PHS47 Cost-Utility Analysis of Rotigotine in Restless Legs Syndrome from the NHS Scotland Perspective

    Nov 1, 2012, 00:00

  • QL1 EQ-5D-5L Valuation Project for the Spanish Population – A Descriptive Overview and Preliminary Results

    Nov 1, 2012, 00:00

  • PSS13 Cost-Effectiveness of Specialized Treatment Based on Cognitive Behavioural Therapy Versus Usual Care for Tinnitus

    Nov 1, 2012, 00:00

  • PHS29 Cost of Treating Patients With Obstructive Sleep Apnea/Hypopnea Sydrome in the Sotiria Chest Hospital in Greece

    Nov 1, 2012, 00:00

  • PCV14 Colesevelam for the Treatment of Hyperlipidemia- A Retrospective ‘Real-World' Analysis From an Integrated Health System

    Nov 1, 2012, 00:00

  • PHS79 The Analysis of the Formulary Committees in Kazakhstani Regions

    Nov 1, 2012, 00:00

  • PDB2 Epidemiology, Patient Burden and Related Costs of Obesity in India

    Nov 1, 2012, 00:00

  • PHS94 Involvement of CNS Specialists in Health Care Provision for Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)- New Data from Nordbaden, Germany, 2003 - 2009

    Nov 1, 2012, 00:00

  • PSU8 Budget Impact Analysis of Anti-Bacterial Suture Use in Appendectomy Procedures in Spain

    Nov 1, 2012, 00:00

  • PRM102 Validation of the Russian Version of Schizophrenia Quality of Life Questionnaire (S-QoL)

    Nov 1, 2012, 00:00

  • PSY42 Effectiveness and Safety of Anti-TNF Agents in Treatment of Moderate to Severe Psoriasis Vulgaris- Results of Work Productivity and Daily Activity Impairment

    Nov 1, 2012, 00:00

  • PMS15 An Economic Evaluation of Denosumab in the Treatment of Postmenopausal Osteoporosis in a Taiwanese Setting

    Nov 1, 2012, 00:00

  • PMH10 Patient Persistence With Buprenorhine/Naloxone Film and Tablet Formulations in the Treatment of Opioid Dependence in the United States- Results From a Large Privately Insured Retrospective Database

    Nov 1, 2012, 00:00

  • PND10 Economic Evaluation of Interferon âeta-1A Versus Interferon âeta-1B in the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) in Iran

    Nov 1, 2012, 00:00

  • PHS81 Health Care Organizations/Services Clustering- Comparison of Several Techniques Using UK Data

    Nov 1, 2012, 00:00

  • PIN16 Tuberculosis Treatment Outcomes in Patients With and Without Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PIH32 The Impact of Periods on Women's Quality of Life in Women Reporting a Problem

    Nov 1, 2012, 00:00

  • PSY48 Developing a National Outcomes Treatment Registry for Hepatitis C Patients in the Era of the DAAs

    Nov 1, 2012, 00:00

  • PMD19 Budget Impact Analysis of Balloon Sinuplasty Versus Classic Functional Endoscopic Sinus Surgery. Using a Budget Impact Model to Identify Country Specific Market Access Strategy

    Nov 1, 2012, 00:00

  • PMS37 Economic Evaluation Model of Biologic Therapies for Moderate to Severe Psoriatic Arthritis in Germany

    Nov 1, 2012, 00:00

  • HC3 The Process of Updating the Items of National Health Insurance Benefits Schedule in Taiwan- is It Fair and Legitimate?

    Nov 1, 2012, 00:00

  • PHP27 The Effect of Retirement on Mental Health

    Nov 1, 2012, 00:00

  • PSY30 Cost-Effectiveness of Ustekinumab in the Management of Moderate-to-Severe Plaque Psoriasis in Mexico

    Nov 1, 2012, 00:00

  • PGI13 Vaccination Status Against Hepatitis B Among Healthy Population of Quetta, Pakistan

    Nov 1, 2012, 00:00

  • PDB61 Research on the Incidence and Cost of Hypoglycemia Episode in Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PIN54 Evaluation of Skin Tests in the Diagnostics of Tuberculosis Infection

    Nov 1, 2012, 00:00

  • PCN54 Economic Burden Associated With Pancreatic Cancer in Europe

    Nov 1, 2012, 00:00

  • PSY20 Infliximab Significantly Improves Symtoms and Quality of Life in Patients With Ankylosing Spondylitis in China

    Nov 1, 2012, 00:00

  • PMD82 Implantable Cardioverter Defibrillator in Italy From 2000 to 2008- A Population-Based Analysis Using Health Administrative Databases

    Nov 1, 2012, 00:00

  • PND37 The Cost-Effectiveness of Buccolam® (Licensed Oromucosal Midazolam) for the Treatment of Acute Epileptic Seizures in the UK; a Hybrid Model Solution

    Nov 1, 2012, 00:00

  • PHS54 Use of Health Care Administrative Databases to Estimate the Health Care Burden of Bone or Bone Marrow Metastatic Deases in Breast Cancer Patients- A Population-Based Study

    Nov 1, 2012, 00:00

  • PCN92 Cost-Effectiveness of Nilotinib Versus Imatinib as First-Line Treatment for Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Russian Federation

    Nov 1, 2012, 00:00

  • PHP30 The Utilization and Expenditure of Reimbursed Digestive Enzyme Agents in Taiwan

    Nov 1, 2012, 00:00

  • PMD11 The Cost of Poor Sample Quality- Assessing the Financial Impact of Sample Rejection and Recollection in Health Care Insitutions

    Nov 1, 2012, 00:00

  • PRM1 What is the Evidence on Using Selected Types of Sutures for Abdominal Surgery – Novel Approach to Create Dynamic Tool for Colleting and Reviewing Available Data

    Nov 1, 2012, 00:00

  • PHS77 Cancer Network Pharmacists Perspective of the First Year of the Cancer Drugs Fund

    Nov 1, 2012, 00:00

  • PHP32 Analyzing the Utilities of Fluoroquinolones at a Regional Teaching Hospital of Southern Taiwan

    Nov 1, 2012, 00:00

  • PHP49 Down-Scheduling Medicines from Prescription to Over-the-Counter- Win-Win?

    Nov 1, 2012, 00:00

  • PSY17 Estimating the Direct Costs of Patients Treated With Eltrombopag in the French Setting

    Nov 1, 2012, 00:00

  • PMD38 The Cost Burden of Unexplained Syncope in Five European Countries- A Database Analysis

    Nov 1, 2012, 00:00

  • PRS6 Self-Reported Adherence to Inhaled Corticosteroids and Beliefs About Medicines in Asthma Patients- A Study From Emergency Room of a Chest Hospital in Delhi, India

    Nov 1, 2012, 00:00

  • PSS2 Comparisons of the Clinical Effectiveness of Treatments for Macular Oedema (MO) Caused by Retinal Vein Occlusion (RVO)

    Nov 1, 2012, 00:00

  • PMD35 Cost Analysis of an Implantable Loop Recorder, Reveal© XT, for the Diagnosis of Atrial Fibrillation in Patients Who Underwent Cryptogenic Stroke From the Perspective of a Tertiary Spanish Hospital

    Nov 1, 2012, 00:00

  • PHP147 Early Access Programmes (EAPs)- Review of the European System

    Nov 1, 2012, 00:00

  • PCV44 Economic Evaluation of a Single-Pill Triple Combination With Valsartan, Amlodipine and Hydrochlorothiazide Against Its Dual Components in Greece. The Generic Substitution Case

    Nov 1, 2012, 00:00

  • PHP15 The Impact of Orphan Drug Incentives on Innovation and Pricing in Niche Therapeutic Markets- A Systematic Review of the Literature

    Nov 1, 2012, 00:00

  • PHS42 Cost-Effectiveness of Infant Vaccination With 10 and 13-Valent Pneumococcal Conjugate Vaccines in the Russian Federation

    Nov 1, 2012, 00:00

  • PDB3 How Different Were They? A Treatment Pattern Analysis of United States Patients With Type 2 Diabetes Mellitus (T2DM) Initiating Injectable Therapy

    Nov 1, 2012, 00:00

  • PHP35 Is There a Difference in Prescription Medication Utilization Between Aged Adults with and Without Disability in the United States?

    Nov 1, 2012, 00:00

  • PRS4 Comparative Efficacy of Aclidinium Bromide 400 Mcg Bid Versus Tiotropium 18 Mcg and 5 Mcg QD as Maintenance Bronchodilator Treatment to Relieve Symptoms in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD)- A Network Met ...

    Nov 1, 2012, 00:00

  • PGI27 Impact of Linaclotide Treatment on Work Productivity and Activity Impairment in Adults With Irritable Bowel Syndrome With Constipation

    Nov 1, 2012, 00:00

  • PSY11 The Effect of Serum Albumin Level With Kabiven for Nutrition Support in a Regional Hospital

    Nov 1, 2012, 00:00

  • PRM156 How to Increase Patient Retention Rate During Their Participation in Longitudinal Studies

    Nov 1, 2012, 00:00

  • PRM22 The Headroom Method of Early Economic Evaluation of Medical Devices- A Useful Tool for Device Developers?

    Nov 1, 2012, 00:00

  • PCV84 Misdiagnosis and Mistreatment of ACE-Inhibitor Induced Cough Decreases Therapy Compliance

    Nov 1, 2012, 00:00

  • PMS32 Cost-Efectiveness Analysis of Anti-Osteoporotic Therapy Among Korean Women With Postmenopausal Osteoporosis

    Nov 1, 2012, 00:00

  • PCN136 Expenditures on Orphan Drugs in Canada, Europe (EU5 + Belgium, Sweden and the Netherlands) and Australia in 2009

    Nov 1, 2012, 00:00

  • PND28 Health Care Costs of Multiple Sclerosis in Germany

    Nov 1, 2012, 00:00

  • PIN72 Cost-Effectiveness Analysis of Palivizumab With Risk Factors for Respiratory Syncytial Virus Prevention

    Nov 1, 2012, 00:00

  • PCN122 Pilot Survey to Estimate Willingness to Pay (WTP) for Prophylactic Granulocyte Colony-Stimulating Factors (G-CSFs) Among Previously Treated Breast Cancer Patients

    Nov 1, 2012, 00:00

  • PND17 Comparing Cost of Therapeutic Plasma Exchange and Intravenous Immunoglobulin Infusion in Treating Guillain-BarrÉ Syndrome

    Nov 1, 2012, 00:00

  • PMD47 Economic Evaluation of Reduced Futile 1st Line Therapy in Metastatic Renal Cell Carcinoma Patients Using Early Angiogenesis-Specific Imaging

    Nov 1, 2012, 00:00

  • PMH42 Assessing Impacts of Major Depressive Disorder (MDD) on Cognitive Function

    Nov 1, 2012, 00:00

  • PCN23 Cost-Effectiveness Analysis of Gefitinib for Lung Cancer- A Population Based Study

    Nov 1, 2012, 00:00

  • PHP72 Making Money Work for Improvement of Patient Care- Success and Shortcomings of Pay-for-Performance Program in Taiwan

    Nov 1, 2012, 00:00

  • Dementia Care in the General Practice Setting- A Cluster Randomized Trial on the Effectiveness and Cost Impact of Three Management Strategies

    Sep 1, 2012, 00:00

  • State-Transition Modeling- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3

    Sep 1, 2012, 00:00

  • Dynamic Transmission Modeling- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5

    Sep 1, 2012, 00:00

  • The Utility Assessment Method Order Influences Measurement of Parents' Risk Attitude

    Sep 1, 2012, 00:00

  • A Comparison of Preferences of Targeted Therapy for Metastatic Renal Cell Carcinoma between the Patient Group and Health Care Professional Group in South Korea

    Sep 1, 2012, 00:00

  • Instructions for Authors

    Sep 1, 2012, 00:00

  • Modeling Good Research Practices—Overview- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

    Sep 1, 2012, 00:00

  • An Evaluation Framework for Funding Drugs for Rare Diseases

    Sep 1, 2012, 00:00

  • Conceptualizing a Model- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2

    Sep 1, 2012, 00:00

  • Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families- Observations from the Dosing Observational Study in Hemophilia

    Sep 1, 2012, 00:00

  • Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada

    Sep 1, 2012, 00:00

  • Model Parameter Estimation and Uncertainty- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

    Sep 1, 2012, 00:00

  • Matching-Adjusted Indirect Comparisons- A New Tool for Timely Comparative Effectiveness Research

    Sep 1, 2012, 00:00

  • Model Transparency and Validation- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7

    Sep 1, 2012, 00:00

  • Multicriteria Decision Analysis for Including Health Interventions in the Universal Health Coverage Benefit Package in Thailand

    Sep 1, 2012, 00:00

  • Relative Effectiveness Assessment of Pharmaceuticals- Similarities and Differences in 29 Jurisdictions

    Sep 1, 2012, 00:00

  • Copyright/Subscription

    Sep 1, 2012, 00:00

  • Innovation and the Burden of Disease—Reply to Letter to the Editor by Catalá-López et al

    Sep 1, 2012, 00:00

  • Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health Technologies

    Sep 1, 2012, 00:00

  • Creating Models That Meet Decision Makers' Needs- A US Payer Perspective

    Sep 1, 2012, 00:00

  • Costs of Adverse Drug Events in German Hospitals—A Microcosting Study

    Sep 1, 2012, 00:00

  • Table of Contents

    Sep 1, 2012, 00:00

  • The View of a Model user on the ISPOR-SMDM Modeling Good Research Task Force Report

    Sep 1, 2012, 00:00

  • FDA Actions Against Health Economic Promotions, 2002–2011

    Sep 1, 2012, 00:00

  • Letter from the Editors

    Sep 1, 2012, 00:00

  • Evaluating New Health Technologies and Disease Burden in Developed Countries

    Sep 1, 2012, 00:00

  • Editorial Board

    Sep 1, 2012, 00:00

  • Modeling using Discrete Event Simulation- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4

    Sep 1, 2012, 00:00

  • Orthopaedic Trauma Care in Haiti- A Cost-Effectiveness Analysis of an Innovative Surgical Residency Program

    Sep 1, 2012, 00:00

  • Quality-of-Life Impact of Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer Patients

    Sep 1, 2012, 00:00

  • Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response

    Sep 1, 2012, 00:00

  • Development of a Decision-Analytic Model for the Application of STR-Based Provenance Testing of Transrectal Prostate Biopsy Specimens

    Sep 1, 2012, 00:00

  • The Inclusion of Informal Care in Applied Economic Evaluation- A Review

    Sep 1, 2012, 00:00

  • Instructions for Authors

    Jul 1, 2012, 00:00

  • Combining Individual-Level Discrete Choice Experiment Estimates and Costs to Inform Health Care Management Decisions about Customized Care- The Case of Follow-Up Strategies after Breast Cancer Treatment

    Jul 1, 2012, 00:00

  • Erratum

    Jul 1, 2012, 00:00

  • Does Responsibility Affect the Public's Valuation of Health Care Interventions? A Relative Valuation Approach to Health Care Safety

    Jul 1, 2012, 00:00

  • How Do Insured Perceive Their Financial Security in the Event of Illness?—A Panel Data Analysis for Germany

    Jul 1, 2012, 00:00

  • Economic Evaluation and the Jordan Rational Drug List- An Exploratory Study of National-Level Priority Setting

    Jul 1, 2012, 00:00

  • Cost-Effectiveness of Expanded Newborn Screening in Texas

    Jul 1, 2012, 00:00

  • The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland

    Jul 1, 2012, 00:00

  • The Maximum Willingness to Pay for Smoking Cessation Method among Adult Smokers in Mexico

    Jul 1, 2012, 00:00

  • Modeling the Risks and Benefits of Depression Treatment for Children and Young Adults

    Jul 1, 2012, 00:00

  • Cost-Effectiveness Analysis of the Bivalent Compared with the Quadrivalent Human Papillomavirus Vaccines in Taiwan

    Jul 1, 2012, 00:00

  • Approach to Fixing the Discrepancy Found in the Wu et al. FACT-P to EQ-5D Questionnaire Mapping Algorithm

    Jul 1, 2012, 00:00

  • Editorial Board

    Jul 1, 2012, 00:00

  • Financial Risk-Sharing in Updating the National List of Health Services in Israel- Stakeholders' Perceived Interests

    Jul 1, 2012, 00:00

  • Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries- How Much Could Be Saved?

    Jul 1, 2012, 00:00

  • Whose Values in Health? An Empirical Comparison of the Application of Adolescent and Adult Values for the CHU-9D and AQOL-6D in the Australian Adolescent General Population

    Jul 1, 2012, 00:00

  • Development of a Database of Instruments for Resource-Use Measurement- Purpose, Feasibility, and Design

    Jul 1, 2012, 00:00

  • Improving the Measurement of QALYs in Dementia- Some Important Considerations

    Jul 1, 2012, 00:00

  • Valuing the Extended Role of Prescribing Pharmacist in General Practice- Results from a Discrete Choice Experiment

    Jul 1, 2012, 00:00

  • Inverse Probability Weighted Least Squares Regression in the Analysis of Time-Censored Cost Data- An Evaluation of the Approach Using SEER-Medicare

    Jul 1, 2012, 00:00

  • Approach to Fixing the Discrepancy Found in the Wu et al. FACT-P to EQ5D Mapping Algorithm—Reply to Letter to the Editor by David Cella, Irina Proskorovsky, and Feng Pan

    Jul 1, 2012, 00:00

  • Interim Scoring for the EQ-5D-5L- Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

    Jul 1, 2012, 00:00

  • Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales- A Cost-Utility Analysis

    Jul 1, 2012, 00:00

  • Validation of the UFS-QOL-Hysterectomy Questionnaire- Modifying an Existing Measure for Comparative Effectiveness Research

    Jul 1, 2012, 00:00

  • Time Trade-Off and Ranking Exercises Are Sensitive to Different Dimensions of EQ-5D Health States

    Jul 1, 2012, 00:00

  • Deriving Input Parameters for Cost-Effectiveness Modeling- Taxonomy of Data Types and Approaches to Their Statistical Synthesis

    Jul 1, 2012, 00:00

  • Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States

    Jul 1, 2012, 00:00

  • Willingness to Pay for Prostate Cancer Treatment among Patients and Their Family Members at 1 Year After Diagnosis

    Jul 1, 2012, 00:00

  • Heterogeneous Effects of Health Insurance on Out-of-Pocket Expenditure on Medicines in Mexico

    Jul 1, 2012, 00:00

  • Table of Contents

    Jul 1, 2012, 00:00

  • Copyright/Subscription

    Jul 1, 2012, 00:00

  • Response to Comments on Mulhern et al., “Improving the Measurement of QALYs in Dementia- Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis”

    Jul 1, 2012, 00:00

  • PMS63 Treatment with Infliximab Improves the Quality of Life of Rheumatoid Arthritis Patients in China

    Jun 1, 2012, 00:00

  • PIN11 Costs of Adverse Events Among Patients With Human Immunodeficiency Virus Treated With Non-Nucleoside Reverse Transcriptase Inhibitors

    Jun 1, 2012, 00:00

  • PCN73 Economic Evaluation of Antithrombotic Therapies in Patients With Cancer in Mexico

    Jun 1, 2012, 00:00

  • PRM27 A Method of Projecting Future Co-Morbidity Prevalence and Health Service Demand in the United Kingdom Population Using the Health Improvement Network (THIN)

    Jun 1, 2012, 00:00

  • PIH77 Annual Overall and Epilepsy-Related Health Care Utilization in Adult Epilepsy Patients in the United States

    Jun 1, 2012, 00:00

  • PIN46 The Effect of Anemia on Health Status and Work Productivity Among Treated Hepatitis C Patients

    Jun 1, 2012, 00:00

  • PSS30 Dosing Patterns and Health Care Provider Interactions for Psoriasis Patients Treated with Ustekinumab

    Jun 1, 2012, 00:00

  • PHP35 Determinants of Participation in Mammography Screening in Taiwan

    Jun 1, 2012, 00:00

  • PMH10 Functional Outcome Measures- A Powerful Tool to Demonstrate Treatment Success in Schizophrenia

    Jun 1, 2012, 00:00

  • PSY3 Adverse Events Associated With Anti-TNF-Alpha- Agents- A Pharmacovigilance Study

    Jun 1, 2012, 00:00

  • PIN65 The Changing Nature of HIV in the Past 5 Years- Implications for Economic Modeling

    Jun 1, 2012, 00:00

  • PDB98 Treatment Patterns and Treatment Restrictions of Patients With Type II Diabetes Receving Care From Home Health Care Agencies, Skilled Nursing Facilities, and Veterans Affairs Settings in the United States

    Jun 1, 2012, 00:00

  • PMD39 Projection of Health Economics Benefits of Continuous Glucose Monitoring Versus Self Monitoring of Blood Glucose in Type 1 Diabetes, in Sweden

    Jun 1, 2012, 00:00

  • PSU39 Identification of Bariatric Surgical Procedures, Comorbidities and Adverse Events in Payor Data

    Jun 1, 2012, 00:00

  • PIN61 Bacteriology and Inappropriate Empiric Therapy in Mixed Complicated Skin and Skin Structure Infections

    Jun 1, 2012, 00:00

  • PIN49 Patient Reported Quality of Life Following Antiretroviral Therapy in a Nigerian Hospital

    Jun 1, 2012, 00:00

  • PDB55 Estimating the Cost-Effectiveness of Premixed Analog Insulin Versus Long Acting Analog Basal Insulin and Premixed Human Insulin in the Management of Type 2 Diabetes- A Long Term Analysis in the United Kingdom (UK)

    Jun 1, 2012, 00:00

  • PIN37 Cost-Effectiveness of Treatment Initiation With Ritonavir-Boosted Atazanavir (ATV/R) and Lopinavir (LPV/R) in Treatment-NaÏve HIV Patients at Different CD4 Levels at Baseline

    Jun 1, 2012, 00:00

  • PCN18 Assessing the Clinical and Economic Burden of Veteran Breast Cancer Patients in the United States

    Jun 1, 2012, 00:00

  • RM3 Antipsychotic Use and Risk of All-Cause Mortality in Elderly Dual Eligible Beneficiaries

    Jun 1, 2012, 00:00

  • PHP30 The Bittersweet Success of Orphan Drugs

    Jun 1, 2012, 00:00

  • PCV44 Financial Impact of Bleeding Events on Total Knee and Hip Replacements in the Argentinean Health Care System

    Jun 1, 2012, 00:00

  • PDB66 Instruments Measuring Treatment Adherence and Compliance in Diabetes Mellitus- a Literature Review

    Jun 1, 2012, 00:00

  • PIN35 Decision Analysis Model Evaluating the Cost-Effectiveness of Fidaxomicin and Vancomycin in the Treatment of Clostridium Difficile Infection (CDI) from a Hospital Perspective

    Jun 1, 2012, 00:00

  • PRM23 Proqolid Database- Where Are We Ten Years After Its Launch?

    Jun 1, 2012, 00:00

  • PSY67 Psychometric Validation of the Pain Impact Questionnaire Revised With a 1-Week Recall

    Jun 1, 2012, 00:00

  • PSU2 Relationship Between Medical Co-Morbidities and Hospitalization Following Elective Total Knee Arthroplasty (TKA)

    Jun 1, 2012, 00:00

  • PHP47 The Economic Impact of a Cost-Effectiveness Threshold on the Innovative Drug Expenditure in Qatar

    Jun 1, 2012, 00:00

  • PMH19 Combination Utilization Patterns and Treatment Predictors in ADHD in a Commercially Insured Population

    Jun 1, 2012, 00:00

  • PSY8 Application of Data Visualization Tool- Treatment Patterns of Medicare Patients With Ankylosing Spondylitis who Initiated Tumor Necrosis Factor Therapy

    Jun 1, 2012, 00:00

  • PMS10 The Cost of Hospitalisation for Knee Osteoarthritis in France in 2010

    Jun 1, 2012, 00:00

  • PMH36 An Economic Evaluation of Screening for Dementia in South Korea

    Jun 1, 2012, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129 (current)
  • 130
  • »